ENC1 Antibody

Code CSB-PA007663GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
ENC1
Alternative Names
CCL 28 antibody; CCL28 antibody; Ectoderm neural cortex protein 1 antibody; Ectoderm-neural cortex protein 1 antibody; Ectodermal neural cortex (with BTB like domain) antibody; ENC 1 antibody; ENC-1 antibody; ENC1 antibody; ENC1_HUMAN antibody; FLJ39259 antibody; Kelch like 35 antibody; Kelch like 37 antibody; Kelch-like protein 37 antibody; KLHL 35 antibody; KLHL35 antibody; KLHL37 antibody; NRPB antibody; Nuclear matrix protein NRP/B antibody; Nuclear restricted protein BTB domain like (brain) antibody; OTTHUMP00000128235 antibody; OTTHUMP00000222054 antibody; p53 induced gene 10 protein antibody; p53-induced gene 10 protein antibody; PIG 10 antibody; PIG10 antibody; TP53I10 antibody; Tumor protein p53 inducible protein 10 antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Human ENC1
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA,WB
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Actin-binding protein involved in the regulation of neuronal process formation and in differentiation of neural crest cells. Down-regulates transcription factor NF2L2/NRF2 by decreasing the rate of protein synthesis and not via a ubiquitin-mediated proteasomal degradation mechanism.
Gene References into Functions
  1. ENC1 interacts with the phosphorylated p62 to impair autophagic degradation of mutant huntingtin protein aggregates. PMID: 26637326
  2. we identified ENC1 and UNC5C as genes with convergent genetic, epigenetic, and transcriptomic evidence supporting a potential role in the dissociation of cognition and neuropathology in an aging population. PMID: 28441426
  3. results suggest that upregulation of ENC-1 contributes to the development of HCL and provides new information on the possible dysregulation of ENC-1 including expression of a novel antisense gene, ENC-1AS PMID: 15459180
  4. NRP/B enhances oxidative stress responses in breast cancer cells via the Nrf2 pathway, identifying a novel role of nuclear matrix protein(s) in oxidative stress responses. PMID: 17875699
  5. NRP/B mutations impair Nrf2-dependent NQO1 induction in primary brain tumors. PMID: 18981988
  6. ENC1 functions as a negative regulator of Nrf2 through suppressing Nrf2 protein translation. PMID: 19424503

Show More

Hide All

Subcellular Location
Nucleus matrix. Cytoplasm. Cytoplasm, cytoskeleton.
Tissue Specificity
Detected in fetal brain tissue, moderate expression in fetal heart, lung and kidney. Highly expressed in adult brain, particularly high in the hippocampus and amygdala, and spinal chord. Detectable in adult pancreas. May be down-regulated in neuroblastoma
Database Links

HGNC: 3345

OMIM: 605173

KEGG: hsa:8507

STRING: 9606.ENSP00000306356

UniGene: Hs.104925

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*